Effectiveness of 6-Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis: an Observational Registry-Based Study
Multiple sclerosis and related disorders（2025）
Key words
Multiple sclerosis, relapsing-remitting,natalizumab,treatment outcome,recurrence
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined